Orestis A. Panagiotou

Center for Biologics Evaluation and Research — United States

Medicine · Health Sciences

31h-index5.2kcitations142works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 and healthcare impacts(21), RNA modifications and cancer(17), Health Systems, Economic Evaluations, Quality of Life(16), Meta-analysis and systematic reviews(14), COVID-19 Clinical Research Studies(11)

Publications140 total

Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part III— Questions for Translational Science and Action Theory
International Journal of Translational Medical Research and Public Health·2025Open Access
Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part I—Coordinated Registry Networks and Systemic Coordinated Inter-Organizational Networks
International Journal of Translational Medical Research and Public Health·2025Open Access
Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part II—How Coordinated Registry Networks Operate Like Systemic Coordinated Inter-Organizational Networks
International Journal of Translational Medical Research and Public Health·2025· 2 citedOpen Access
Genetically determined body mass index is associated with diffuse large B‐cell lymphoma in polygenic and Mendelian randomization analyses
International Journal of Cancer·2025Open Access
Greater Physician Supply Associated with Lower Mortality in Rural Counties: A 23-Year County-Level Longitudinal Observational Study
INQUIRY The Journal of Health Care Organization Provision and Financing·2025Open Access
Real‐World Evidence in New Drug and Biologics License Application Approvals During Fiscal Years 2020–2022
Clinical Pharmacology & Therapeutics·2025· 4 citedOpen Access
Predictors and Drivers of End-of-Life Medicare Spending Among Older Adults with Solid Tumors: A Population-Based Study
Cancers·2025Open Access
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium
UNC Libraries·2025Open Access
Predictors and Drivers of End-of-Life Medicare Spending Among Older Adults with Solid Tumors: A Population-Based Study
Preprints.org·2025Open Access
A Comprehensive Framework for Evaluating the Value Created by Real-World Evidence for Diverse Stakeholders: The Case for Coordinated Registry Networks
Therapeutic Innovation & Regulatory Science·2024· 7 cited
RWD139 Enhancing Public Health Through Timely Detection: Assessing the Value of Real-World Evidence With a Cardiovascular Defibrillator Leads Case Study
Value in Health·2024Open Access
Predictors of high-intensity care at the end of life among older adults with solid tumors: A population-based study
Journal of Geriatric Oncology·2024· 3 citedOpen Access
Genetically Determined Height and Risk of Non-hodgkin Lymphoma
UNC Libraries·2024Open Access
County-Level Mandates Were Generally Effective At Slowing COVID-19 Transmission
Health Affairs·2024· 4 cited
Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study
eLife·2023· 3 citedOpen Access
Author response: Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study
2023· 1 citedOpen Access
Supplementary Table 5 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Data from Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
2023Open Access
Supplementary Table 3 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 6 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
page 1 of 7Next →

Frequent Co-authors

John P. A. Ioannidis(11), Jeremy L. Warner(9), Toni K. Choueiri(8), Ziad Bakouny(8), Dimitrios Farmakiotis(8), Andrew Schmidt(8), Sanjay Mishra(8), Sholom Wacholder(8), Dimpy P. Shah(7), Petros Grivas(6), Gilberto Lopes(5), Michael A. Thompson(5), Pamela Egan(5), Elizabeth A. Griffiths(5), Shilpa Gupta(5), Ali Raza Khaki(5), Rana R. McKay(5), Nathan A. Pennell(5), Gary H. Lyman(5), Εvangelos Εvangelou(5)